Celularity Inc. has announced a securities purchase agreement with certain investors for a private placement involving the issuance and sale of 739,286 shares of its Class A common stock at a purchase price of $1.40 per share. In conjunction with this agreement, the company has also revised the exercise price of certain warrants held by these investors to $2.50 per share and extended their expiration date to June 30, 2030. The transaction, expected to close during the week of July 21, 2025, is anticipated to generate gross proceeds of $1,035,000, which the company plans to use for working capital and general corporate purposes.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。